375 related articles for article (PubMed ID: 28609172)
1. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.
Hoeller A; Ehrlich L; Golic M; Herse F; Perschel FH; Siwetz M; Henrich W; Dechend R; Huppertz B; Verlohren S
Hypertens Pregnancy; 2017 May; 36(2):151-160. PubMed ID: 28609172
[TBL] [Abstract][Full Text] [Related]
2. Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.
Ehrlich L; Hoeller A; Golic M; Herse F; Perschel FH; Henrich W; Dechend R; Huppertz B; Verlohren S
Hypertens Pregnancy; 2017 May; 36(2):175-185. PubMed ID: 28494189
[TBL] [Abstract][Full Text] [Related]
3. Reduced angiogenic factor expression in intrauterine fetal growth restriction using semiquantitative immunohistochemistry and digital image analysis.
Alahakoon TI; Zhang W; Arbuckle S; Zhang K; Lee V
J Obstet Gynaecol Res; 2018 May; 44(5):861-872. PubMed ID: 29392826
[TBL] [Abstract][Full Text] [Related]
4. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
5. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
[TBL] [Abstract][Full Text] [Related]
6. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
7. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
8. sFlt-1/PlGF ratio for the prediction of the time of delivery.
Graupner O; Lobmaier SM; Ortiz JU; Karge A; Kuschel B
Arch Gynecol Obstet; 2018 Sep; 298(3):567-577. PubMed ID: 29968165
[TBL] [Abstract][Full Text] [Related]
9. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia.
Stolz M; Zeisler H; Heinzl F; Binder J; Farr A
Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274
[TBL] [Abstract][Full Text] [Related]
10. Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Gómez-Montes E; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2013 May; 41(5):530-7. PubMed ID: 23303638
[TBL] [Abstract][Full Text] [Related]
11. Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine.
Li SW; Ling Y; Jin S; Lin YF; Chen ZJ; Hu CX; Wang MH; Yao MZ
Asian Pac J Trop Med; 2014 Aug; 7(8):663-667. PubMed ID: 25149383
[TBL] [Abstract][Full Text] [Related]
12. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.
Schoofs K; Grittner U; Engels T; Pape J; Denk B; Henrich W; Verlohren S
J Perinat Med; 2014 Jan; 42(1):61-8. PubMed ID: 23929878
[TBL] [Abstract][Full Text] [Related]
13. Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia.
Lecarpentier E; Zsengellér ZK; Salahuddin S; Covarrubias AE; Lo A; Haddad B; Thadhani RI; Karumanchi SA
Hypertension; 2020 Sep; 76(3):875-883. PubMed ID: 32654553
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
15. The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes.
Chang YS; Chen CN; Jeng SF; Su YN; Chen CY; Chou HC; Tsao PN; Hsieh WS
Pediatr Neonatol; 2017 Dec; 58(6):529-533. PubMed ID: 28571908
[TBL] [Abstract][Full Text] [Related]
16. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
17. The role of disordered angiogenesis tissue markers (sflt-1, Plgf) in present day diagnosis of preeclampsia.
Kwiatkowski S; Kwiatkowska E; Torbe A
Ginekol Pol; 2019; 90(3):173-176. PubMed ID: 30950008
[TBL] [Abstract][Full Text] [Related]
18. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
Tang P; Xu J; Xie BJ; Wang QM
Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
[TBL] [Abstract][Full Text] [Related]
19. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia.
Boulanger H; Drouin D; Largilliere C; Lefèvre G
J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):695-697. PubMed ID: 31085278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
